Japanese guideline for allergic conjunctival diseases

Allergology International

Volumn 60, Issue 2, 2011, Pages 191-203

  Takamura, Etsuko ^a   Uchio, Eiichi ^b   Ebihara, Nobuyuki ^c   Ohno, Shigeaki ^d   Ohashi, Yuichi ^e   Okamoto, Shigeki ^f   Kumagai, Naoki ^g   Satake, Yoshiyuki ^h   Shoji, Jun ⁱ   Nakagawa, Yayoi ^j   Namba, Kenichi ^d   Fukagawa, Kazumi ^k,l   Fukushima, Atsuki ^m   Fujishima, Hiroshi ⁿ  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f Okamoto Eye Clinic   (Japan)

^g Kumagai Eye Clinic   (Japan)

^h BUILDING RESEARCH INSTITUTE   (Japan)

ⁱ NIHON UNIVERSITY   (Japan)

^j Nakagawa Eye Clinic   (Japan)

^k Ryogoku Eye Clinic   (Japan)

^l KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^m Department of Ophthalmology ^*  (Japan)

ⁿ TSURUMI UNIVERSITY   (Japan)

more..

Author keywords

Allergic conjunctivitis; Antiallergic eye drop; Atopic keratoconjunctivitis; Giant papillary conjunctivitis; Vernal keratoconjunctivitis

Indexed keywords

ARTIFICIAL TEAR; BETAMETHASONE; BETAMETHASONE SODIUM PHOSPHATE; CYCLOSPORIN; CYTOKINE; CYTOTOXIC FACTOR; DEXAMETHASONE SODIUM METASULFOBENZOATE; DEXAMETHASONE SODIUM PHOSPHATE; FLUOROMETHOLONE; HYDROCORTISONE ACETATE; IMMUNOSUPPRESSIVE AGENT; NEOMYCIN; PAPILOCK; PREDNISOLONE; STEROID; TACROLIMUS; TALYMUS; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ALLERGIC CONJUNCTIVA DISEASE; ALLERGIC CONJUNCTIVITIS; ALLERGIC DISEASE; ATOPIC KERATOCONJUNCTIVITIS; B LYMPHOCYTE; CLINICAL EVALUATION; CLINICAL FEATURE; CONJUNCTIVA DISEASE; CONJUNCTIVAL HYPEREMIA; CONTACT LENS; CORNEA; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; EOSINOPHIL; EPIDEMIOLOGICAL DATA; GIANT PAPILLARY CONJUNCTIVITIS; HELPER CELL; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOSUPPRESSIVE TREATMENT; JAPANESE; LACRIMAL FLUID; LIMBAL CONJUNCTIVA; PALPEBRAL CONJUNCTIVA; PATHOPHYSIOLOGY; PERENNIAL ALLERGIC CONJUNCTIVITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SEASONAL ALLERGIC CONJUNCTIVITIS; SELF CARE; SUSPENSION; TREATMENT PLANNING; VERNAL CONJUNCTIVITIS;

EID: 79959574808     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.11-RAI-0335     Document Type: Review

References (18)

1. Japanese Ocular Allergology Society. [Guidelines for the clinical management of allergic conjunctival disease (2nd edition)]. Nippon Ganka Gakkai Zasshi [J Jpn Ophthalmol Soc] 2010;114:831-70(in Japanese).
2. Metz DP, Bacon AS, Holgate S, Lightman SL. Phenotypic characterization of T cells infiltrating the conjunctiva in chronic allergic eye disease. J Allegy Clin Immunol 1996; 98:686-96.
3. Shoji J, Inada N, Saito K, Takaura N, Iwasaki Y, Sawa M. Immunohistochemical study on follicular dendritic cell of conjunctiva-associated lymphoid tissue. Jpn J Ophthalmol 1998;42:1-7.
4. Maggi E, Biswas P, Del Prete G et al. Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol 1991;146:1169-74.
5. Fujishima H, Takeuchi T, Shinozaki N, Saito I, Tsubota K. Measurement of IL-4 in tears of patients with seasonal allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Immunol 1995;102:395-8.
6. Matsuura N, Uchio E, Nakazawa M et al. Predominance of infiltrating IL-4-producing T cells in conjunctiva of patients with allergic conjunctival disease. Curr Eye Res 2004;29:235-43.
7. Fukagawa K, Nakajima T, Saito H et al. IL-4 induces eotaxin production in corneal keraticytes but not in epithelial cells. Int Arch Allergy Immunol 2000;121:144-50.
8. Kumagai N, Fukuda K, Ishimura Y, Nishida T. Synergistic induction of eotaxin expression in human keratocytes by TNF-bband IL-4 or IL-3. Invest Ophthalmol Vis Sci 2000; 41:1448-53.
9. Fukuda K, Fujitsu Y, Seki K, Kumagai N, Nishida T. Differential expression of thymus-and activation-regulated chemokine (CCL17) and macrophage-derived chemokine (CCL22) by human fibroblasts from cornea, skin, and lung. J Allergy Clin Immunol 2003;111:520-6.
10. Nakagawa Y. [Conjunctival cytology]. Nippon Ganka Kiyou [Folia Ophthalmol Jpn] 1988;39:200-1(in Japanese).
11. Nakagawa Y, Ishizaki M, Okamoto S et al. [Clinical evaluation of immunochromatography for measurement of total IgE concentration in tear fluid in allergic conjunctivitis]. Rinsyo Ganka [Jpn J Clin Ophthalmol] 2006;60:951-4 (in Japanese).
12. Ohno S, Uchio E, Ishizaki M et al. [New clinical evaluation standard and seriousness classification of allergic conjunctival diseases]. Iyaku Journal [Medicine & Drug Journal] 2001;37:1341-9(in Japanese).
13. Armaly MF. Statistical attributes of steroid hypertensive response in the clinically normal eye. Invest Ophthalmol Vis Sci 1965;4:187-97.
14. Ohji M, Kuwayama Y, Kinoshita H et al. [Incidence of elevated intraocular pressure following topical corticosteroid in children]. Rinsyo Ganka [Jpn J Clinic Ophthalmol] 1992;45:749-52(in Japanese).
15. Ebihara N, Ohashi Y, Uchino E et al. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. J Ocul Pharmacol Ther 2009;25:365-72.
16. Ohashi Y, Ebihara N, Fujishima H et al. A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis. J Ocular Pharmacology and Therapeutics 2010;26:165-73.
17. Juniper EF, Guyatt GH, Ferrie PJ, King DR. Sodium cromoglycate eye drops: Regular versus "as needed" use in the treatment of seasonal allergic conjunctivitis. J Allergy Clin Immunol 1994;94:36-43.
18. Ebihara N. [Treatment of Allergic Symptoms with Preseasonal Instillation of Ibudilast]. Atarasii Ganka [Journal of the eye] 2003;20:259-62(in Japanese).